7
Views
35
CrossRef citations to date
0
Altmetric
Article

Heat Shock-Independent Induction of Multidrug Resistance by Heat Shock Factor 1

, , &
Pages 580-591 | Received 11 Jul 2005, Accepted 19 Oct 2005, Published online: 27 Mar 2023
 

Abstract

The screening of two different retroviral cDNA expression libraries to select genes that confer constitutive doxorubicin resistance has in both cases resulted in the isolation of the heat shock factor 1 (HSF1) transcription factor. We show that HSF1 induces a multidrug resistance phenotype that occurs in the absence of heat shock or cellular stress and is mediated at least in part through the constitutive activation of the multidrug resistance gene 1 (MDR-1). This drug resistance phenotype does not correlate with an increased expression of heat shock-responsive genes (heat shock protein genes, or HSPs). In addition, HSF1 mutants lacking HSP gene activation are also capable of conferring multidrug resistance, and only hypophosphorylated HSF1 complexes accumulate in transduced cells. Our results indicate that HSF1 can activate MDR-1 expression in a stress-independent manner that differs from the canonical heat shock-activated mechanism involved in HSP induction. We further provide evidence that the induction of MDR-1 expression occurs at a posttranscriptional level, revealing a novel undocumented role for hypophosphorylated HSF1 in posttranscriptional gene regulation.

Supplemental material for this article may be found at http://mcb.asm.org/.

We thank A. Vervish for flow cytometry analysis; D. Iancu for technical help in performing sensitive run-on assays; J. Wang for the gift of plasmids pcDNA3-dn-hHSF1 (originally named pcDNA3-mHSF1), pcDNA3-c-hHSF1, and pGL3-phsp70B; K. W. Scotto for the gift of pMDR(−1202); C. Baum for the gift of pSF91m3; A. Laurand for the gift of pSF-MDR; R. E. Kingston for the gift of pBabe-puro-hHSF1-flag wt and phenylalanine (3F) mutant derivatives and for pBabe-puro-Flag-Gal4(1-94)HSF-ABC-wt; S. Moore for the gift of HepG2 cells; and L. L. Pritchard for critical reading of the manuscript.

This work was supported by a grant from the Association pour la Recherche sur le Cancer (contract no. 4200XA0031F to T.T.).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.